'Quick course' neoadjuvant chemotherapy with cisplatin, bleomycin and vincristine in advanced cervical cancer

Gynecologic and Obstetric Investigation

Volumn 58, Issue 2, 2004, Pages 109-113

  Singh, Kishor C ^a   Agarwal, Alka ^a   Agarwal, Sarla ^a   Rajaram, Shalini ^a   Goel, Neerja ^a   Agarwal, Neera ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Bleomycin; Carcinoma cervix; Cisplatin; Neoadjuvant chemotherapy; Vincristine; Weekly course

Indexed keywords

BLEOMYCIN; CISPLATIN; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; EVALUATION; FEMALE; HUMAN; LUNG TOXICITY; NAUSEA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SYMPTOM; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; VOMITING;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VINCRISTINE;

EID: 4344633798     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078863     Document Type: Article

References (9)

1. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Luthra UK: Biennial report: National Cancer Registry Programme 1988-89. ICMR, New Delhi, 1992, pp 23-25.
3. Kumar L: Current status of neoadjuvant chemotherapy in carcinoma cervix; in Singh KC, Goel N, Rajaram S (eds): Current Practice in Obstetrics and Gynecology. Young Brothers, New Delhi, 1999, vol 1, pp 183-198.
4. Porzio G, Ficorella C, Toro G, Paris I, Ricevuto E, Marchetti P: Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer. Tumori 2001;87:25-26.
5. Chang HC, Lai CH, Chen MS, et al: Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine and bleomycin in bulky, advanced cervical carcinoma: A pilot study. Gynecol Oncol 1992;44:182-188.
6. Hwang YY, Moon H, Cho SH, Kim KT, Moon YJ, Kim SR, Kim DS: Ten-year survival of patients with locally advanced, stage Ib-IIb cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 2001;82:88-93.
7. Sardi JE, Giaroli A, Sananes C, Ferreira M, Soderini A, Bermudez A, Snaidas L, Vighi S, Gomez Rueda N, di Paola G: Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: The final results. Gynecol Oncol 1997;67:61-69.
8. Napolitano U, Imperato F, Mossa B, Framarino ML, Marziani R, Marzetti L: The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): A long-term randomized trial. Eur J Gynaecol Oncol 2003;24:51-59.
9. Huang HJ, Chang TC, Hong JH, Tseng CJ, Chou HH, Huang KG, Lai CH: Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (64 cm) stage IB and IIA cervical carcinoma. Int J Gynecol Cancer 2003;13:204-211.